Dhan Sidhartha Chand
5Patents
1h-index
17Co-inventors
40Inventor score
Filing activity: Apr 12, 2018 → Aug 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11021537B2 | Anti-TIGIT antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11680098B2 | Antibodies that specifically bind human CD96 | Chemistry; Metallurgy | 0 | Active |
| US11098117B2 | Anti-CD137 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11242385B2 | Anti-CD137 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11718669B2 | Anti-TIGIT and anti-CD96 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.